MGUS and the role of the microenvironment in myeloma

Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, gives us an update on the role of the microenvironment in monoclonal gammopathy of undetermined significance (MGUS). She talks about the part played by immune cells and stromal cells, and how they interact with the tumor to cause disease progression. She addresses the key challenges, including the difficulty in obtaining cells for research and progress. Recorded at the 2017 European Multiple Myeloma Academy (EMMA) in Vienna, Austria.
This program was sponsored by Celgene through an unrestricted educational grant to Video Journal of Hematological Oncology.

Share this video